Recombinant CD44v9 (Marker of Tumor Metastasis) Antibody, Clone: [CD44v9/2344R], Rabbit, Monoclonal

Produktübersicht

• Artikelname: Recombinant CD44v9 (Marker of Tumor Metastasis) Antibody, Clone: [CD44v9/2344R], Rabbit, Monoclonal
• Artikelnummer: NBT-960-RBM9-P1
• Hersteller Artikelnummer: 960-RBM9-P1
• Alternativnummer: NBT-960-RBM9-P1-100
• Hersteller: NeoBiotechnologies
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: IHC
• Spezies Reaktivität: Human
• Immunogen: Recombinant fragment corresponding to the v9 domain of human CD44
• Alternative Synonym: LHR, BA-1, chondroitin sulfate proteoglycan 8 (CSPG8), Epican, Extracellular Matrix Receptor III (ECM III), GP90 Lymphocyte Homing Adhesion Receptor, HCAM, HCELL, hematopoietic cell E- and L-selectin ligand, Heparan Sulfate Proteoglycan, Hermes Antigen,

Produktbeschreibung

This antibody recognizes an epitope encoded by exon v4 on the variant portion of human CD44. The CD44 molecule belongs to a family of cellular adhesion molecules found on a wide range of normal and malignant cells in epithelial, mesothelial and hemopoies

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [CD44v9/2344R]
• Molekulargewicht: 80-95kDa
• NCBI: 960
• UniProt: P16070
• Formulierung: 200ug/ml of Ab Purified by Protein A. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.